|
Showing the most relevant articles for your search:AMEX:ANX Date | Time | Source | Headline | Symbol | Company | 09/09/2011 | 4:56PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | AMEX:ANX | Mast Therapeutics, Inc. |
09/09/2011 | 9:15AM | PR Newswire (US) | Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $7.50 Target Price | AMEX:ANX | Mast Therapeutics, Inc. |
09/06/2011 | 8:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12 | AMEX:ANX | Mast Therapeutics, Inc. |
08/30/2011 | 8:00AM | PR Newswire (US) | ADVENTRX Provides Update on All Three Pipeline Products | AMEX:ANX | Mast Therapeutics, Inc. |
08/15/2011 | 6:51PM | Dow Jones News | UPDATE: Icahn Reports New Stakes In Vector Group, El Paso - Filing | AMEX:ANX | Mast Therapeutics, Inc. |
08/15/2011 | 6:19PM | Dow Jones News | Icahn Reports New Stakes In Vector Group, El Paso - Filing | AMEX:ANX | Mast Therapeutics, Inc. |
08/11/2011 | 5:10AM | Zacks | Company News for August 11, 2011 - Corporate Summary | AMEX:ANX | Mast Therapeutics, Inc. |
08/10/2011 | 7:56AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
08/10/2011 | 4:14AM | Zacks | Zacks #1 Rank Additions for Wednesday - Tale of the Tape | AMEX:ANX | Mast Therapeutics, Inc. |
08/09/2011 | 6:57PM | PR Newswire (US) | ADVENTRX Receives Complete Response Letter for Exelbine NDA | AMEX:ANX | Mast Therapeutics, Inc. |
08/08/2011 | 4:09PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ANX | Mast Therapeutics, Inc. |
08/08/2011 | 11:37AM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | AMEX:ANX | Mast Therapeutics, Inc. |
08/08/2011 | 11:28AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
08/08/2011 | 8:00AM | PR Newswire (US) | ADVENTRX Reports Second Quarter 2011 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
08/04/2011 | 8:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 31st Annual Canaccord Genuity Growth Conference on August 11 | AMEX:ANX | Mast Therapeutics, Inc. |
07/25/2011 | 8:00AM | PR Newswire (US) | ADVENTRX Announces Appointment of Senior Vice President, Commercial | AMEX:ANX | Mast Therapeutics, Inc. |
07/22/2011 | 5:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
07/22/2011 | 5:19PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:ANX | Mast Therapeutics, Inc. |
07/21/2011 | 4:14AM | Zacks | Zacks #1 Rank Additions for Thursday - Tale of the Tape | AMEX:ANX | Mast Therapeutics, Inc. |
07/08/2011 | 6:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
07/08/2011 | 6:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
07/08/2011 | 4:14PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
06/23/2011 | 4:30PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
06/22/2011 | 9:15AM | PR Newswire (US) | Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50 | AMEX:ANX | Mast Therapeutics, Inc. |
06/17/2011 | 12:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
06/17/2011 | 12:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
06/17/2011 | 12:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
06/17/2011 | 12:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
06/16/2011 | 6:18PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:ANX | Mast Therapeutics, Inc. |
06/16/2011 | 4:09PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|